Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Cardiol Therapeutics Inc. (CRDL) had Free Cash Flow per Share of $-0.20 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.64M |
|
-- |
|
-- |
|
$3.19M |
|
$-3.19M |
|
$0.55M |
|
$-2.64M |
|
$-2.64M |
|
$-2.64M |
|
$-2.64M |
|
$-2.64M |
|
$-2.64M |
|
$-3.19M |
|
$-3.17M |
|
86.99M |
|
86.99M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$16.82M |
|
$0.08M |
|
$0.08M |
|
$16.90M |
|
$4.05M |
|
$0.06M |
|
$0.06M |
|
$4.11M |
|
$12.80M |
|
$12.80M |
|
$12.80M |
|
100.26M |
|
| Cash Flow Statement Financials | |
$-17.07M |
|
$-0.02M |
|
$11.12M |
|
$21.89M |
|
$15.33M |
|
$-6.56M |
|
$7.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.16 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.66% |
|
-20.66% |
|
-15.64% |
|
-20.56% |
|
$0.13 |
|
|
Free Cash Flow per Share |
$-0.20 |
$-0.20 |
|